Literature DB >> 25378494

The influenza virus neuraminidase protein transmembrane and head domains have coevolved.

Diogo V da Silva1, Johan Nordholm1, Dan Dou1, Hao Wang1, Jeremy S Rossman2, Robert Daniels3.   

Abstract

UNLABELLED: Transmembrane domains (TMDs) from single-spanning membrane proteins are commonly viewed as membrane anchors for functional domains. Influenza virus neuraminidase (NA) exemplifies this concept, as it retains enzymatic function upon proteolytic release from the membrane. However, the subtype 1 NA TMDs have become increasingly more polar in human strains since 1918, which suggests that selection pressure exists on this domain. Here, we investigated the N1 TMD-head domain relationship by exchanging a prototypical "old" TMD (1933) with a "recent" (2009), more polar TMD and an engineered hydrophobic TMD. Each exchange altered the TMD association, decreased the NA folding efficiency, and significantly reduced viral budding and replication at 37°C compared to at 33°C, at which NA folds more efficiently. Passaging the chimera viruses at 37°C restored the NA folding efficiency, viral budding, and infectivity by selecting for NA TMD mutations that correspond with their polar or hydrophobic assembly properties. These results demonstrate that single-spanning membrane protein TMDs can influence distal domain folding, as well as membrane-related processes, and suggest the NA TMD in H1N1 viruses has become more polar to maintain compatibility with the evolving enzymatic head domain. IMPORTANCE: The neuraminidase (NA) protein from influenza A viruses (IAVs) functions to promote viral release and is one of the major surface antigens. The receptor-destroying activity in NA resides in the distal head domain that is linked to the viral membrane by an N-terminal hydrophobic transmembrane domain (TMD). Over the last century, the subtype 1 NA TMDs (N1) in human H1N1 viruses have become increasingly more polar, and the head domains have changed to alter their antigenicity. Here, we provide the first evidence that an "old" N1 head domain from 1933 is incompatible with a "recent" (2009), more polar N1 TMD sequence and that, during viral replication, the head domain drives the selection of TMD mutations. These mutations modify the intrinsic TMD assembly to restore the head domain folding compatibility and the resultant budding deficiency. This likely explains why the N1 TMDs have become more polar and suggests the N1 TMD and head domain have coevolved.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25378494      PMCID: PMC4300628          DOI: 10.1128/JVI.02005-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Polar side chains drive the association of model transmembrane peptides.

Authors:  H Gratkowski; J D Lear; W F DeGrado
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

Review 2.  Virus membrane fusion proteins: biological machines that undergo a metamorphosis.

Authors:  R E Dutch; T S Jardetzky; R A Lamb
Journal:  Biosci Rep       Date:  2000-12       Impact factor: 3.840

3.  Interhelical hydrogen bonding drives strong interactions in membrane proteins.

Authors:  F X Zhou; M J Cocco; W P Russ; A T Brunger; D M Engelman
Journal:  Nat Struct Biol       Date:  2000-02

4.  N-linked glycans direct the cotranslational folding pathway of influenza hemagglutinin.

Authors:  Robert Daniels; Brad Kurowski; Arthur E Johnson; Daniel N Hebert
Journal:  Mol Cell       Date:  2003-01       Impact factor: 17.970

5.  GALLEX, a measurement of heterologous association of transmembrane helices in a biological membrane.

Authors:  Dirk Schneider; Donald M Engelman
Journal:  J Biol Chem       Date:  2002-11-21       Impact factor: 5.157

6.  A DNA transfection system for generation of influenza A virus from eight plasmids.

Authors:  E Hoffmann; G Neumann; Y Kawaoka; G Hobom; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

7.  A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site.

Authors:  Larisa V Gubareva; Marina S Nedyalkova; Dmitri V Novikov; K Gopal Murti; Erich Hoffmann; Frederick G Hayden
Journal:  J Gen Virol       Date:  2002-11       Impact factor: 3.891

8.  Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus.

Authors:  L J Mitnaul; M N Matrosovich; M R Castrucci; A B Tuzikov; N V Bovin; D Kobasa; Y Kawaoka
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

9.  The organizing principle in the formation of the T cell receptor-CD3 complex.

Authors:  Matthew E Call; Jason Pyrdol; Martin Wiedmann; Kai W Wucherpfennig
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

10.  Type II transmembrane domain hydrophobicity dictates the cotranslational dependence for inversion.

Authors:  Dan Dou; Diogo V da Silva; Johan Nordholm; Hao Wang; Robert Daniels
Journal:  Mol Biol Cell       Date:  2014-08-27       Impact factor: 4.138

View more
  11 in total

1.  An Amino Acid in the Stalk Domain of N1 Neuraminidase Is Critical for Enzymatic Activity.

Authors:  Mark Zanin; Susu Duan; Sook-San Wong; Gyanendra Kumar; Pradyumna Baviskar; Emily Collin; Charles Russell; Subrata Barman; Benjamin Hause; Richard Webby
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

2.  Identification of Residues That Affect Oligomerization and/or Enzymatic Activity of Influenza Virus H5N1 Neuraminidase Proteins.

Authors:  Meiling Dai; Hongbo Guo; Jos C F M Dortmans; Jojanneke Dekkers; Johan Nordholm; Robert Daniels; Frank J M van Kuppeveld; Erik de Vries; Cornelis A M de Haan
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

3.  Design of the Recombinant Influenza Neuraminidase Antigen Is Crucial for Its Biochemical Properties and Protective Efficacy.

Authors:  Jin Gao; Laura Klenow; Lisa Parsons; Tahir Malik; Je-Nie Phue; Zhizeng Gao; Stephen G Withers; John Cipollo; Robert Daniels; Hongquan Wan
Journal:  J Virol       Date:  2021-10-06       Impact factor: 5.103

4.  Antigenic comparison of the neuraminidases from recent influenza A vaccine viruses and 2019-2020 circulating strains.

Authors:  Jin Gao; Xing Li; Laura Klenow; Tahir Malik; Hongquan Wan; Zhiping Ye; Robert Daniels
Journal:  NPJ Vaccines       Date:  2022-07-14       Impact factor: 9.399

5.  N-Linked Glycan Sites on the Influenza A Virus Neuraminidase Head Domain Are Required for Efficient Viral Incorporation and Replication.

Authors:  Henrik Östbye; Jin Gao; Mira Rakic Martinez; Hao Wang; Jan-Willem de Gier; Robert Daniels
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

6.  Structural restrictions for influenza neuraminidase activity promote adaptation and diversification.

Authors:  Hao Wang; Dan Dou; Henrik Östbye; Rebecca Revol; Robert Daniels
Journal:  Nat Microbiol       Date:  2019-08-26       Impact factor: 17.745

Review 7.  Replication-Competent Influenza A Viruses Expressing Reporter Genes.

Authors:  Michael Breen; Aitor Nogales; Steven F Baker; Luis Martínez-Sobrido
Journal:  Viruses       Date:  2016-06-23       Impact factor: 5.048

8.  Multiple nuclear-replicating viruses require the stress-induced protein ZC3H11A for efficient growth.

Authors:  Shady Younis; Wael Kamel; Tina Falkeborn; Hao Wang; Di Yu; Robert Daniels; Magnus Essand; Jorma Hinkula; Göran Akusjärvi; Leif Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-02       Impact factor: 11.205

Review 9.  Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement.

Authors:  Dan Dou; Rebecca Revol; Henrik Östbye; Hao Wang; Robert Daniels
Journal:  Front Immunol       Date:  2018-07-20       Impact factor: 7.561

10.  The CD28 Transmembrane Domain Contains an Essential Dimerization Motif.

Authors:  Scott A Leddon; Margaret M Fettis; Kristin Abramo; Ryan Kelly; David Oleksyn; Jim Miller
Journal:  Front Immunol       Date:  2020-07-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.